A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David H Wang, MD PhD
VA Ann Arbor Healthcare System, Ann Arbor, MI
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Va Palo Alto Health Care System, Palo Alto, Ca
Palo Alto, California, United States
Recruiting - Va Ann Arbor Healthcare System, Ann Arbor, Mi
Ann Arbor, Michigan, United States
David H Wang, MD PhDRecruiting - Durham Va Medical Center, Durham, Nc
Durham, North Carolina, United States
Recruiting - Va Portland Health Care System, Portland, Or
Portland, Oregon, United States
Recruiting - Va North Texas Health Care System Dallas Va Medical Center, Dallas, Tx
Dallas, Texas, United States
Recruiting - Michael E. Debakey Va Medical Center, Houston, Tx
Houston, Texas, United States
Recruiting - Va Puget Sound Health Care System Seattle Division, Seattle, Wa
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2024
- Primary completion
- 30 Apr 2029
- Completion
- 15 Jun 2029
- Last update posted
- 5 Nov 2025
- Registered enrollment
- 78
- Registry id
- NCT05563766
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.